ClinicalTrials.gov
public full text
Public Domain
Eliquis Regulatory Post Marketing Surveillance (rPMS)
The objective of this regulatory Post-Marketing Surveillance in Korea is to reconfirm the clinical usefulness of Eliquis through collecting, reviewing, identifying and verifying the safety and effectiveness information about Eliquis in general practice
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sequential analysis for post-marketing drug safety surveillance using routinely collected electronic healthcare data: a scoping review.#354638
- Qlaira rPMS (Regulatory Post Marketing Surveillance) Study in Korea#1172257
- A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta#839299
- A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA#1164913
- 16 CFR Part 1105 — Contributions to Costs of Participants in Development of Consumer Product Safety Standards#506122
Record · ID 1047691
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive